These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 1802981)

  • 1. Solubilization of ovine growth hormone with 2-hydroxypropyl-beta-cyclodextrin.
    Simpkins JW
    J Parenter Sci Technol; 1991; 45(6):266-9. PubMed ID: 1802981
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of 2-hydroxypropyl-beta-cyclodextrin on the aqueous solubility of drugs and transdermal delivery of 17 beta-estradiol.
    Loftsson T; Bodor N
    Acta Pharm Nord; 1989; 1(4):185-94. PubMed ID: 2590460
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of 2-hydroxypropyl-beta-cyclodextrin on pharmacokinetics of digoxin in rabbits and humans.
    He ZG; Li YS; Zhang TH; Tang X; Zhao C; Zhang RH
    Pharmazie; 2004 Mar; 59(3):200-2. PubMed ID: 15074593
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-aggregatory effect of cyclodextrins in the refolding process of recombinant growth hormones from Escherichia coli inclusion bodies.
    Bajorunaite E; Cirkovas A; Radzevicius K; Larsen KL; Sereikaite J; Bumelis VA
    Int J Biol Macromol; 2009 Jun; 44(5):428-34. PubMed ID: 19428477
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of 2-hydroxypropyl-beta-cyclodextrin as a solubilizing and stabilizing excipient for protein drugs.
    Brewster ME; Hora MS; Simpkins JW; Bodor N
    Pharm Res; 1991 Jun; 8(6):792-5. PubMed ID: 2062811
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclodextrin-enhanced solubilization of pentachlorophenol in water.
    Hanna K; de Brauer Ch; Germain P
    J Environ Manage; 2004 May; 71(1):1-8. PubMed ID: 15084354
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of 2-hydroxypropyl-beta-cyclodextrin on the solubility, stability, and pharmacological activity of the chemical delivery system of TRH analogs.
    Wu WM; Wu J; Bodor N
    Pharmazie; 2002 Feb; 57(2):130-4. PubMed ID: 11878189
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of hydroxypropyl-beta-cyclodextrin on the solubility, stability and in-vitro release of ciprofloxacin for ocular drug delivery.
    Bozkir A; Denli ZF; Basaran B
    Acta Pol Pharm; 2012; 69(4):719-24. PubMed ID: 22876616
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclodextrin (CD) complexes of cholesterol--their potential use in reducing dietary cholesterol intake.
    Somogyi G; Posta J; Buris L; Varga M
    Pharmazie; 2006 Feb; 61(2):154-6. PubMed ID: 16526565
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention of precipitation of phenytoin in an infusion fluid by hydroxypropyl beta-cyclodextrin.
    McDonald C; Muzumdar PP
    J Clin Pharm Ther; 1998 Jun; 23(3):235-9. PubMed ID: 9831976
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preparation of amorphous indomethacin from aqueous 2,6-di-O-methyl-beta-cyclodextrin solution.
    Iohara D; Hirayama F; Ishiguro T; Arima H; Uekama K
    Int J Pharm; 2008 Apr; 354(1-2):70-6. PubMed ID: 18093762
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complexation of morin with three kinds of cyclodextrin. A thermodynamic and reactivity study.
    Jullian C; Orosteguis T; Pérez-Cruz F; Sánchez P; Mendizabal F; Olea-Azar C
    Spectrochim Acta A Mol Biomol Spectrosc; 2008 Nov; 71(1):269-75. PubMed ID: 18262835
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of parenteral formulation for a novel angiogenesis inhibitor, CKD-732 through complexation with hydroxypropyl-beta-cyclodextrin.
    Kim JH; Lee SK; Ki MH; Choi WK; Ahn SK; Shin HJ; Hong CI
    Int J Pharm; 2004 Mar; 272(1-2):79-89. PubMed ID: 15019071
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Formation of natamycin:cyclodextrin inclusion complexes and their characterization.
    Koontz JL; Marcy JE
    J Agric Food Chem; 2003 Nov; 51(24):7106-10. PubMed ID: 14611179
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Solubilization and complexation of the antileukotrienic drug Quinlukast in aqueous solutions of cyclodextrins].
    Kopecký F; Kopecká B
    Ceska Slov Farm; 2005 May; 54(3):137-40. PubMed ID: 15945461
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Compatibility of hydroxypropyl-beta-cyclodextrin with algal toxicity bioassays.
    Fai PB; Grant A; Reid BJ
    Environ Pollut; 2009 Jan; 157(1):135-40. PubMed ID: 18775592
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of 2-hydroxypropyl-beta-cyclodextrin on the ocular absorption of dexamethasone and dexamethasone acetate.
    Usayapant A; Karara AH; Narurkar MM
    Pharm Res; 1991 Dec; 8(12):1495-9. PubMed ID: 1808612
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of hydroxypropyl-beta-cyclodextrin on the transdermal permeation and skin accumulation of oxybenzone.
    Felton LA; Wiley CJ; Godwin DA
    Drug Dev Ind Pharm; 2002 Oct; 28(9):1117-24. PubMed ID: 12455470
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Solubilities of trimethoprim and sulfamethoxazole at various pH values and crystallization of trimethoprim from infusion fluids.
    McDonald C; Faridah
    J Parenter Sci Technol; 1991; 45(3):147-51. PubMed ID: 1886043
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of pH and water-soluble polymers on the aqueous solubility of nimesulide in the absence and presence of beta-cyclodextrin derivatives.
    Alexanian C; Papademou H; Vertzoni M; Archontaki H; Valsami G
    J Pharm Pharmacol; 2008 Nov; 60(11):1433-9. PubMed ID: 18957163
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.